CIN85/RukL is a novel binding partner of nephrin and podocin and mediates slit diaphragm turnover in podocytes
Kalirin-7 controls activity-dependent structural and functional plasticity of dendritic spines
At a glance Direct interaction data / none published in human trials as of May 2026 BPC-157 primary mechanism / nitric oxide system modulation, angiogenesis, and GI cytoprotection Ashwagandha primary mechanism / HPA-axis modulation, cortisol reduction, withanolide-driven adaptogenesis Overlap concern / both influence the hypothalamic-pituitary-adrenal and hypothalamic-pituitary-thyroid axes Suggested dose separation / 30 to 60 minutes between oral ashwagandha and oral BPC-157 Monitoring labs / TSH, free T4, morning cortisol at baseline and every 8 to 12 weeks Ashwagandha cortisol reduction / 30.5% decrease in serum cortisol vs
Drug Interactions : BPC-157's interaction with nitric oxide pathways and growth hormone receptors raises concerns about interference with medications (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), anticoagulants, and hormonal therapies)
This guide reviews evidence-based supplementation strategies, including protein, vitamins, and minerals that support metabolic health, while identifying products to avoid
It protects the skin from environmental damage, brightens hyperpigmentation, evens out the skin tone, and stimulates collagen production
